CoChat

Systematic review of the limited evidence base for treatments of Eustachian tube dysfunction: a health technology assessment

Norman, G., Llewellyn, A., Harden, M., Coatesworth, A., Kimberling, D., Schilder, A., McDaid, C. · 2014 · Clinical Otolaryngology
Cited by 92

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: The H ealth T echnology A ssessment programme commissioned a wide‐ranging review of treatments for adult E ustachian tube dysfunction. Treatments range from advice and observation and pharmacological treatments to surgical options. Objective: (i) To assess the evidence for interventions for adults with a clinical diagnosis of E ustachian tube dysfunction and (ii) to identify priorities for future research. Type of review: Systematic review (PROSPERO registration CRD 42012003035) adhering to PRISMA guidance. Search: An extensive search of 15 databases including MEDLINE, EMBASE and CENTRAL (up to O ctober 2012). Evaluation method: Controlled and uncontrolled studies of interventions for adult E ustachian tube dysfunction were included. Because of insufficient data, the protocol was amended to also include controlled studies with mixed adult/child populations. Risk of bias was assessed. Narrative synthesis was employed due to high clinical heterogeneity. Results: Interventions assessed were pharmacological treatments [two randomised controlled trials (RCTs), one controlled non‐randomised trial (CCT), 159 patients]; mechanical pressure equalisation devices (one randomised controlled trial, one CCT, 48 patients); and surgery, including laser tuboplasty (seven case series, 192 patients), balloon dilatation (three case series, 103 patients), myringotomy without grommet insertion (two case series, 121 patients), transtubal steroids (one case series, 11 patients) and laser coagulation (one retrospective controlled study, 40 patients). All studies had high risk of bias except two pharmacological trials; one had low risk and one unclear risk. No evidence was found for many treatments. The single low risk of bias RCT (n = 91; 67% adults) showed no effect of nasal steroids and favoured placebo for improved middle ear function (RR 1.20, 95% CI 0.91–1.58) and symptoms (P = 0.07). Other studies showed improvements in middle ear function for mechanical devices, antihistamine/ephedrine and nasal decongestant, but they had significant methodological weaknesses including insufficient length of follow‐up. None of the surgical studies were adequately controlled, and many reported high levels of co‐intervention. Therefore, observed benefits for tuboplasty and balloon dilatation in symptoms, middle ear function or hearing could not be reliably attributed to the interventions assessed. There was variability in definitions of the condition. Conclusion: Eustachian tube dysfunction is a poorly defined condition. Due to the limited and poor‐quality evidence, it is inappropriate to make conclusions on the effectiveness of any intervention; the evidence base is insufficient to guide recommendations for a trial of any particular intervention. Consensus on diagnostic criteria for Eustachian tube dysfunction is required to inform inclusion criteria of future trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/coa.12220

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 92

Metadata

Authors
Norman, G., Llewellyn, A., Harden, M., Coatesworth, A., Kimberling, D., Schilder, A., & McDaid, C.
Venue
Clinical Otolaryngology
Publisher
Wiley
Published
2014-02
Volume
39
Issue
1
Pages
6-21
ISSN
  • 0307-7772 (ISSN-L)
  • 1749-4478
  • 1749-4486
OpenAlex
W2003637263
Cited by
92
References
3
FWCI
1.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review of the limited evidence base for treatments of Eustachian tube dysfunction: a health technology assessment. https://app.cochat.ai/papers/10.1111/coa.12220
The paper
Norman, G., Llewellyn, A., Harden, M., Coatesworth, A., Kimberling, D., Schilder, A., & McDaid, C. (2014). Systematic review of the limited evidence base for treatments of Eustachian tube dysfunction: a health technology assessment. Clinical Otolaryngology. https://doi.org/10.1111/coa.12220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.